The Gene Panel Market is gaining momentum as genetic testing becomes increasingly important in precision medicine and disease risk assessment. According to MRFR, the market was valued at USD 3.56 billion in 2025 and is forecast to reach USD 14.03 billion by 2035.

Gene panel technologies allow laboratories to examine multiple disease-related genes simultaneously, providing a practical alternative to testing individual genes separately. Falling sequencing costs and improvements in laboratory throughput are helping make these tests more accessible across clinical and research environments.

Cancer-related testing represents a significant source of demand, particularly for hereditary cancer risk assessment and tumor profiling. Pharmacogenetics is also gaining attention as healthcare providers explore genetic information to support more personalized medication decisions.

Test kits represented about 60.05% of market revenue in 2025, while testing services are projected to grow at a 15.23% CAGR through 2035. Hospitals and clinics remain major end users, with diagnostic laboratories expanding their role in high-volume genomic testing.

The market is expected to benefit from continued development of AI-powered genomic analysis and cloud-based interpretation tools. These technologies can help laboratories manage growing amounts of genetic data while supporting faster and more standardized reporting.

Strengthen your strategy with data-backed research insights:

US Needle-Free Injection Market Outlook

India Nasal Spray Market Analysis

China Heart Failure Drugs Market Distribution

South Korea Ophthalmic Topical Therapeutics Market Size

Italy Genomics Market Share